Stockreport

Cathie Wood's moves entering 2026: bets on gene-editing and genomics names, adds BEAM, TWST, NTLA [Seeking Alpha]

Beam Therapeutics Inc.  (BEAM) 
PDF ARK Invest sharply increased its exposure to gene-editing and genomics companies, buying led by Beam Therapeutics ( Newsletters for Every Investor Get daily, sector [Read more]